Isis Pharmaceuticals Announces Positive Phase 2 Results In Patients With Spinal Muscular Atrophy By: TalkMarkets June 11, 2015 at 12:17 PM EDT Shares of Isis are up 4% after posting positive phase 2 results in patients with Spinal Muscular Atrophy. Read More >>